MOLM-16 Human acute myeloid leukemia cells

Human acute myeloid leukemia cell MOLM-16, also known as MOLM16.
MOLM-16 cells were established in 1999 by Japanese scientist Matsuo Y and others, isolated from the peripheral blood cells of a 77-year-old woman suffering from acute myeloid leukemia. After failing chemotherapy, the patient experienced recurrent acute myeloid leukemia (AML-M0 type). MOLM-16 cells originate from pro-megakaryocytic leukemia cells of differentiated acute leukemia, possess a myelogen/NK precursor phenotype, and are commonly used in leukemia-related research.

Animal Species: Human

Tissue Source:peripheral blood; Disease: Acute myeloid leukemia (AML-M0 type)

Morphology:Lymphoblast-like, suspended growth; Grow in single or multicellular clusters

Culture Medium Formula:RPMI-1640 Complete Medium（MD0203）

Gas phase: Air, 95%; Carbon dioxide, 5%. Temperature: 37℃. 

Freezing conditions:  90% FBS (SD0200) + 10% DMSO

Complete cryopreservation solution: No Programmed Cryopreservation Cells Solution (low Serum)(SD0001)

Declaration: The product is for scientific research purposes only.